drugset / Trial / NCT00882635
The STREAM Percutaneous Coronary Intervention Anticoagulant Sub-study
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the safety and efficacy of Enoxaparin and Unfractionated Heparin in St Elevation Myocardial Infarction patients undergoing primary percutaneous coronary intervention.
Timeline
- Start
- 2008-10
- Primary completion
- 2012-06
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enoxaparin sodium | Other / unclassified | 0.25 mg/kg | Intravenous |
| Subject | Enoxaparin sodium | Other / unclassified | 0.5 mg/kg | Intravenous |
| Subject | Enoxaparin sodium | Other / unclassified | 1 mg/kg | Intravenous |
| Comparator | Heparin | Other / unclassified | 12 iu/kg | Intravenous |
| Comparator | Heparin | Other / unclassified | 70 iu/kg | Intravenous |